Anti-Serum Amyloid A Antibody [S3]

This primary antibody reagent from Antibodies.com targets the acute-phase protein Serum Amyloid A (SAA) and is supplied as a lyophilised powder in a 100 µg vial. Raised in mouse host cells as a monoclonal of the IgM isotype, the unconjugated clone [S3] is reactivity-confirmed against human SAA and validated for use in ELISA workflows that quantify inflammatory biomarkers in research samples.

Lyophilisation supports flexible reconstitution and stable bench storage when the vial is kept refrigerated and protected from light until first use. Because circulating SAA concentrations climb rapidly during acute inflammation, infection, tissue injury, and chronic inflammatory conditions, this reagent supports investigations into sepsis, cardiovascular risk stratification, rheumatoid arthritis, and related disease models where reproducible ELISA readouts of SAA are required.

The unconjugated presentation lets individual labs apply their own conjugation or detection chemistry depending on assay design, while the monoclonal IgM [S3] format provides consistent specificity from batch to batch. Each vial is delivered free of carrier preservatives, eliminating the need for immediate aliquoting on receipt and simplifying downstream handling in long-running studies.